Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2001, p. 3660-3662, Vol. 45, No. 12
Bristol-Myers Squibb Company Pharmaceutical
Research Institute, Wallingford, Connecticut
Received 20 April 2001/Returned for modification 20 August
2001/Accepted 12 September 2001
BMS-284756 (T-3811ME), a novel des-F(6) quinolone, was
tested in the supercoiling inhibition and cleavable complex assays against Escherichia coli DNA gyrase, a target of
quinolones. The results suggest that BMS-284756 has the same mechanism
of action against DNA gyrase as other quinolones and a similar level of potency.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3660-3662.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mechanism of Action of the Des-F(6) Quinolone
BMS-284756 Measured by Supercoiling Inhibition and Cleavable
Complex Assays
*
Corresponding author. Present address: Merck Research
Laboratories, Merck & Co., Inc., RY80Y-315, 126 E. Lincoln Ave.,
Rahway, NJ 07065-0900. Phone: (732) 594-3509. Fax: (732) 594-5878. E-mail: John_Barrett2{at}merck.com.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |